Multimorbidity trends in United States adults, 1988–2014

Journal of the American Board of Family Medicine

Volumn 31, Issue 4, 2018, Pages 503-513

  King, Dana E ^a   Xiang, Jun ^a   Pilkerton, Courtney S ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cross Sectional Studies; Health Care Costs; Health Policy; Multimorbidity; Nutrition Surveys; Prevalence; Primary Health Care; Socioeconomic Factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; CAUCASIAN; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MULTIPLE CHRONIC CONDITIONS; OBESITY; PREVALENCE; RACE; SEX DIFFERENCE; SOCIOECONOMICS; UNITED STATES; CHRONIC DISEASE; ECONOMICS; HEALTH CARE COST; NUTRITION; YOUNG ADULT;

ADULT; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MULTIMORBIDITY; NUTRITION SURVEYS; OBESITY; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 85049874221     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2018.04.180008     Document Type: Article

References (49)

1. Jindai K, Nielson CM, Vorderstrasse BA, Quinones AR. Multimorbidity and functional limitations among adults 65 or older, NHANES 2005–2012. Prev Chronic Dis 2016;13:E151.
2. Lebwohl M. Does Treatment of psoriasis reduce cardiovascular comorbidities? J Invest Dermatol 2017;137:1612–3.
3. Mazarati AM, Lewis ML, Pittman QJ. Neurobehav-ioral comorbidities of epilepsy: role of inflammation. Epilepsia 2017;58:48–56.
4. Lehrke M, Marx N. Diabetes mellitus and heart failure. Am J Cardiol 2017;120:S37-S47.
5. Yin HL, Yin SQ, Lin QY, Xu Y, Xu HW, Liu T. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine (Baltimore) 2017;96:e6836.
6. Dong Q, Liu H, Yang D, Zhang Y. Diabetes mellitus and arthritis: is it a risk factor or comorbidity?: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e6627.
7. Radner H. Multimorbidity in rheumatic conditions. Wien Klin Wochenschr 2016;128:786–790.
8. Pefoyo AJ, Bronskill SE, Gruneir A, et al. The increasing burden and complexity of multimorbidity. BMC Public Health 2015;15:415.
9. Rosbach M, Andersen JS. Patient-experienced burden of treatment in patients with multi-morbidity- a systematic review of qualitative data. PLoS One 2017;12:e0179916.
10. Nunes BP, Flores TR, Mielke GI, Thume E, Fac-chini LA. Multimorbidity and mortality in older adults: a systemic review and meta-analysis. Arch Gerontol Geriatr 2016;67:130–8.
11. Landi F, Liperoti R, Russo A, et al. Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. J Clin Epidemiol 2010;63:752–9.
12. Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens E, Kromhout D. Prevalence of morbidity and mulitmorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001;54:680–6.
13. Chwastiak LA, Rosencheck RA, Desai R, Kazis LE. Association of psychiatric illness and all-cause mortality in the national department of veterans affairs health care system. Psychosom Med. 2010;72:817–22.
14. Censin JC, Nowak C, Cooper N, Bergsten P, Todd JA, Fall T. Childhood adiposity and risk of type 1 diabetes: a Mendelian randomization study. PLoS Med 2017;14:e1002362.
15. Reho JJ, Rahmouni K. Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci (Lond) 2017;131:1689–700.
16. King DE, Mainous AG 3rd, Matheson EM, Everett CJ. Impact of healthy lifestyle on mortality in people with normal blood pressure, LDL cholesterol, and C-reactive protein. Eur J Prev Cardiol 2013;20:73–9.
17. Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 2017; 960:1–17.
18. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res 2017;183:57–70.
19. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 2016;375:794–8.
20. Kivimaki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2017;2:e277-e85.
21. National Center for Health Statistics. NHANES survey methods and analytic guidelines. Available from: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Accessed May 2018.
22. National Center for Health Statistics. NHANES analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988–1994). Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf. Published October 1996. Accessed May 2018.
23. American Diabetes Association. Standards of medical care in diabetes-2018 abridged for primary care providers. Clin Diabetes 2018;36:14–37.
24. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20.
25. Cho YK, Jung CH, Kang YM, et al. 2013 ACC/AHA cholesterol guideline versus 2004 NCEP ATP III guideline in the prediction of coronary artery calcification progression in a Korean population. J Am Heart Assoc 2016;5:e003410.
26. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004. Am J Kidney Dis 2007;50:918–26.
27. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.
28. National Center for Health Statistics. Continuous NHANES web tutorial: specifying weighting parameters. Available from: https://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/intro. htm. Updated May 2013. Accessed March 2018.
29. National Center for Health Statistics. Continuous NHANES web tutorial: age standardization and population counts. Available from: https://www.cdc.gov/nchs/tutorials/nhanes/NHANESAnalyses/ AgeStandardization/age_standardization_intro.htm. Updated May 2014. Accessed May 2018.
30. Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 2014;11:E62.
31. Centers for Disease Control and Prevention. Co-morbidities. Available from: https://www.cdc.gov/arthritis/data_statistics/comorbidities.htm. Updated February 2018. Accessed May 2018.
32. DuGoff EH, Canudas-Romo V, Buttorff C, Leff B, Anderson GF. Multiple chronic conditions and life expectancy: a life table analysis. Med Care 2014;52: 688–94.
33. Van Oostrom SH, Gijsen R, Stirbu I, et al. Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS One 2016;11: e0160264.
34. Pefoyo AJ, Bronskill SE, Gruneir A, et al. The increasing burden and complexity of multimorbidity. BMC Public Health 2015;15:415.
35. Rocca WA, Boyd CM, Grossardt BR, et al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ ethnicity. Mayo Clin Proc 2014;89:1336–49.
36. Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015;385:549–62.
37. Krishnaswami A, Maurer MS, Alexander KP. Contextualizing myocardial infarction: comorbidities and priorities in older adults. Am J Med 2017;130: 1144 –7.
38. Dieter BP, Tuttle KR. Dietary strategies for cardiovascular health. Trends Cardiovasc Med 2017;27: 295–313.
39. Shook RP, Hand GA, Drenowatz C, et al. Low levels of physical activity are associated with dysregulation of energy intake and fat mass gain over 1 year. Am J Clin Nutr 2015;102:1332– 8.
40. Ali M, Li Y, O’Neal WT, Soliman EZ. Tobacco exposure as determined by serum cotinine and sub-clinical myocardial injury in individuals free from cardiovascular disease. Am J Cardiol 2017;120: 1114–7.
41. Amrock SM, Abraham CZ, Jung E, Morris PB, Shapiro MD. Risk factors for mortality among individuals with peripheral arterial disease. Am J Cardiol 2017;120:862–7.
42. Bruce MA, Martins D, Duru K, et al. Church attendance, allostatic load and mortality in middle aged adults. PLoS One 2017;12:e0177618.
43. King DE, Matheson E, Chirina S, Shankar A, Bro-man-Fulks J. The status of baby boomers’ health in the United States; the healthiest generation? JAMA Intern Med 2013;173:385–6.
44. Fleisch Marcus A, Illescas AH, Hohl BC, Llanos AA. Relationships between social isolation, neighborhood poverty, and cancer mortality in a population-based study of US adults. PLoS One 2017;12: e0173370.
45. Wang HH, Wang JJ, Lawson KD, et al. Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Ann Fam Med 2015;13:164–7.
46. Chung RY, Mercer SW, Yip BH, et al. The association between types of regular primary care and hospitalization among people with and without multimorbidity: a household survey on 25,780 Chinese. Sci Rep 2016;6:29758.
47. Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health 2018;42:186–194.
48. Hilderink HB, Plasmans MH, Snijders BE, Boshui-zen HC, Poos MJ, van Gool CH. Accounting for multimorbidity can affect the estimation of the burden of disease: a comparison of approaches. Arch Public Health 2016;74:37.
49. Florence CS, Zhou C, Luo F, Xu L. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 2016;54:901–6.